Differential Expression of MICA and MICB in Cervical Cancer Cell Lines
Author Information
Author(s): Susana del Toro-Arreola, Naela Arreygue-Garcia, Adriana Aguilar-Lemarroy, Angel Cid-Arregui, Miriam Jimenez-Perez, Jesse Haramati, Patricio Barros-Nuñez, Oscar Gonzalez-Ramella, Alicia del Toro-Arreola, Pablo Ortiz-Lazareno, Georgina Hernandez-Flores, Alejandro Bravo-Cuellar, Adrian Daneri-Navarro, Luis F Jave-Suarez
Primary Institution: Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara
Hypothesis
The study aims to describe the expression pattern of MICA and MICB in human cervical cancer cell lines infected or not with human papillomavirus.
Conclusion
MICA and MICB are differentially expressed in cervical cancer cell lines, with HPV-positive cells showing higher MICA levels.
Supporting Evidence
- MICA and MICB showed differential expression patterns among HPV-infected and non-infected cell lines.
- HPV-positive cell lines had higher levels of MICA compared to HPV-negative cell lines.
- All cell lines released higher amounts of soluble MICB than soluble MICA.
Takeaway
This study found that two important proteins, MICA and MICB, behave differently in cervical cancer cells, especially those infected with HPV.
Methodology
The study used flow cytometry, Western blot analysis, and Real-Time PCR to assess the expression of MICA and MICB in various cervical cancer cell lines.
Limitations
The study did not assess the expression of MICA/B ligands in primary HPV-infected keratinocytes.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website